Jorge Gomez Tejeda Zanudo
Overview
Explore the profile of Jorge Gomez Tejeda Zanudo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
440
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bhakhri P, Phelps K, Gomez Tejeda Zanudo J, Gwozdz E, Ko S, Hendrickson T, et al.
Ther Adv Rare Dis
. 2024 Dec;
5:26330040241304440.
PMID: 39691183
Background: Approximately 25% of cancer patients are diagnosed with rare cancers and face unique challenges. Decentralized patient-partnered research efforts, like Count Me In provide an avenue for patients to participate...
2.
Klughammer J, Abravanel D, Segerstolpe A, Blosser T, Goltsev Y, Cui Y, et al.
Nat Med
. 2024 Oct;
30(11):3236-3249.
PMID: 39478111
Although metastatic disease is the leading cause of cancer-related deaths, its tumor microenvironment remains poorly characterized due to technical and biospecimen limitations. In this study, we assembled a multi-modal spatial...
3.
Gomez Tejeda Zanudo J, Barroso-Sousa R, Jain E, Jin Q, Li T, Buendia-Buendia J, et al.
Nat Commun
. 2024 Mar;
15(1):2446.
PMID: 38503755
The landscape of cyclin-dependent kinase 4/6 inhibitor (CDK4/6i) resistance is still being elucidated and the optimal subsequent therapy to overcome resistance remains uncertain. Here we present the final results of...
4.
Lipsyc-Sharf M, Jain E, Collins L, Rosenberg S, Ruddy K, Tamimi R, et al.
JCO Precis Oncol
. 2023 Jun;
7:e2300076.
PMID: 37364233
Purpose: Erb-B2 receptor tyrosine kinase 2 ()-positive breast cancer (BC) is particularly common in young women. Genomic features of -positive tumors before and after chemotherapy and trastuzumab (chemo + H)...
5.
Tolaney S, Tarantino P, Graham N, Tayob N, Pare L, Villacampa G, et al.
Lancet Oncol
. 2023 Mar;
24(3):273-285.
PMID: 36858723
Background: We aimed to report on long-term outcomes of patients with small, node-negative, HER2-positive breast cancer treated with adjuvant paclitaxel and trastuzumab and to establish potential biomarkers to predict prognosis....
6.
Toribio M, Cetlin M, Fulda E, Chu S, Gomez Tejeda Zanudo J, Poteat T, et al.
Transgend Health
. 2023 Feb;
8(1):64-73.
PMID: 36824383
Purpose: Through a survey-based approach, we sought to investigate regional differences in gender-affirming hormone therapy (GAHT) prescribing practices, as well as HIV screening and prevention practices among clinicians providing care...
7.
Newby E, Gomez Tejeda Zanudo J, Albert R
Chaos
. 2022 Jul;
32(6):063102.
PMID: 35778133
In network control theory, driving all the nodes in the Feedback Vertex Set (FVS) by node-state override forces the network into one of its attractors (long-term dynamic behaviors). The FVS...
8.
Nasrollahi F, Gomez Tejeda Zanudo J, Campbell C, Albert R
Phys Rev E
. 2021 Dec;
104(5-1):054304.
PMID: 34942827
Attractors in Boolean network models representing complex systems such as ecological communities correspond to long-term outcomes (e.g., stable communities) in such systems. As a result, identifying efficient methods to find...
9.
Rozum J, Deritei D, Park K, Gomez Tejeda Zanudo J, Albert R
Bioinformatics
. 2021 Dec;
38(5):1465-1466.
PMID: 34875008
Summary: pystablemotifs is a Python 3 library for analyzing Boolean networks. Its non-heuristic and exhaustive attractor identification algorithm was previously presented in Rozum et al. (2021). Here, we illustrate its...
10.
Alcon C, Gomez Tejeda Zanudo J, Albert R, Wagle N, Scaltriti M, Letai A, et al.
Cells
. 2021 Aug;
10(7).
PMID: 34359829
Breast cancer is the most frequent type of cancer and the major cause of mortality in women. The rapid development of various therapeutic options has led to the improvement of...